236 related articles for article (PubMed ID: 21273149)
1. [Immunosuppressive treatments: mechanisms of action and clinical use].
Thervet E; Zuber J; Sberro R; Canaud G; Anglicheau D; Snanoudj R; Mamzer-Bruneel MF; Martinez F; Legendre C
Nephrol Ther; 2011 Dec; 7(7):566-81. PubMed ID: 21273149
[TBL] [Abstract][Full Text] [Related]
2. An update on chemical pharmacotherapy options for the prevention of kidney transplant rejection with a focus on costimulation blockade.
Kälble F; Schaier M; Schäfer S; Süsal C; Zeier M; Sommerer C; Morath C
Expert Opin Pharmacother; 2017 Jun; 18(8):799-807. PubMed ID: 28460546
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive minimization with mTOR inhibitors and belatacept.
Diekmann F
Transpl Int; 2015 Aug; 28(8):921-7. PubMed ID: 25959589
[TBL] [Abstract][Full Text] [Related]
4. [Immunosuppressive treatment].
Niaudet P
Nephrol Ther; 2011 Dec; 7(7):592-8. PubMed ID: 22118788
[TBL] [Abstract][Full Text] [Related]
5. Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.
Kirk AD; Guasch A; Xu H; Cheeseman J; Mead SI; Ghali A; Mehta AK; Wu D; Gebel H; Bray R; Horan J; Kean LS; Larsen CP; Pearson TC
Am J Transplant; 2014 May; 14(5):1142-51. PubMed ID: 24684552
[TBL] [Abstract][Full Text] [Related]
6. Biological agents in kidney transplantation: belatacept is entering the field.
Wéclawiak H; Kamar N; Ould-Mohamed A; Cardeau-Desangles I; Rostaing L
Expert Opin Biol Ther; 2010 Oct; 10(10):1501-8. PubMed ID: 20726688
[TBL] [Abstract][Full Text] [Related]
7. Belatacept prophylaxis against organ rejection in adult kidney-transplant recipients.
Del Bello A; Marion O; Milongo D; Rostaing L; Kamar N
Expert Rev Clin Pharmacol; 2016; 9(2):215-27. PubMed ID: 26691282
[TBL] [Abstract][Full Text] [Related]
8. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
Tönshoff B; Höcker B
Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
[TBL] [Abstract][Full Text] [Related]
9. [Perspectives in clinical immunology].
Rolla G; Ferrero N; Bergia R; Guida G
Recenti Prog Med; 2006 Dec; 97(12):787-96. PubMed ID: 17252738
[TBL] [Abstract][Full Text] [Related]
10. [Toward an evidence-based immunosuppression].
Pascual J
Nefrologia; 2001; 21(6):524-5; discussion 526-7. PubMed ID: 11881421
[No Abstract] [Full Text] [Related]
11. [New immunodepressant drugs for the prevention and control of kidney transplant rejection].
Segoloni GP
G Ital Nefrol; 2005; 22(1):3-15. PubMed ID: 15786373
[TBL] [Abstract][Full Text] [Related]
12. Are calcineurin inhibitors-free regimens ready for prime time?
Vincenti F
Kidney Int; 2012 Nov; 82(10):1054-60. PubMed ID: 22622502
[TBL] [Abstract][Full Text] [Related]
13. [Immunosuppression for kidney transplant recipients: current strategies].
Alberú J; Urrea EM
Rev Invest Clin; 2005; 57(2):213-24. PubMed ID: 16524061
[TBL] [Abstract][Full Text] [Related]
14. Calcineurin-inhibitor-sparing immunosuppressive protocols.
Bestard O; Cruzado JM; Grinyó JM
Transplant Proc; 2005 Nov; 37(9):3729-32. PubMed ID: 16386520
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin inhibitor-free immunosuppression in renal transplantation.
Parada B; Mota A; Nunes P; Macário F; Pratas J; Bastos C; Figueiredo A
Transplant Proc; 2005; 37(6):2759-61. PubMed ID: 16182803
[TBL] [Abstract][Full Text] [Related]
16. New developments in immunosuppressive therapy in renal transplantation.
Gourishankar S; Turner P; Halloran P
Expert Opin Biol Ther; 2002 Jun; 2(5):483-501. PubMed ID: 12079485
[TBL] [Abstract][Full Text] [Related]
17. [Biological treatment following renal transplantation].
Viklický O
Vnitr Lek; 2011; 57(7-8):650-3. PubMed ID: 21877601
[TBL] [Abstract][Full Text] [Related]
18. Rationale for using belatacept in combination with sirolimus.
Wéclawiak H; Kamar N; Ould-Mohamed A; Cardeau-Desangles I; Rostaing L
Transplant Proc; 2010 Nov; 42(9 Suppl):S29-31. PubMed ID: 21095447
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin inhibitor-sparing regimens based on mycophenolic acid after kidney transplantation.
Kamar N; Del Bello A; Belliere J; Rostaing L
Transpl Int; 2015 Aug; 28(8):928-37. PubMed ID: 25557802
[TBL] [Abstract][Full Text] [Related]
20. [Evidences in immunosuppression in the maintenance of renal transplantation].
Hernández D; González-Posada JM
Nefrologia; 2005; 25(4):369-80. PubMed ID: 16231502
[No Abstract] [Full Text] [Related]
[Next] [New Search]
